本刊特点：目次收录（知网）,外文期刊,
期刊基本信息
出版周期：年刊 级别：国际刊号
中国国内刊号：无CN刊号
国际标准刊号：eISSN
杂志社联系方式
地址：北京市东城区东黄城根北街16号
邮编：100717
电话：13910124623；010-64034856
官方网站：https://vcm.edpsciences.org/
杂志征稿投稿要求
《可视化癌症医学（英文）》
（Visualized Cancer Medicine）期刊简介
【中国抗癌协会杂志社官方网站信息】
期刊名称
中文 可视化癌症医学
英文 Visualized Cancer Medicine
期刊简介
VCM 聚焦肿瘤医学，拟刊登以视频证据为主要发现的高水平肿瘤医学基础研究、转化研究和临床研究成果，以及配有视频的介绍肿瘤学最近进展的综述文章，籍此促进肿瘤医学的进步并提高肿瘤罹患者的近、远期生存率和生存质量；本刊为英文版季刊，以开放获取（OA）形式出版。VCM 是中国抗癌协会肿瘤微环境专业委员会的官方杂志。由科学出版社下属中科数字出版传媒有限公司（中科数媒）及法国 EDP 公司负责创刊工作，由科学出版社出版发行、广州泰和肿瘤医院协办，编辑部设立在中科数媒和 EDP 公司，主编办公室依托于广州泰和肿瘤医院。2020年9月17日正式创刊。
VCM 是同行评议的国际科学期刊，三位主编分别是：中国抗癌协会肿瘤微环境专业委员会主任委员、广州泰和肿瘤医院院长钱朝南教授，英国牛津大学知名病理学家 Francesco Pezzella 教授以及浙江大学转化医学研究院院长吕志民教授。VCM 的强大编委会团队包括了中国科学院院士、孙逸仙纪念医院院长宋尔卫教授，美国科学院院士、MD 安德森癌症中心前任院长 Ronald DePinho 教授，国际肿瘤微环境协会主席、以色列技术学院的 Yuval Shaked 教授，瑞典 Karolinska 学院的曹义海教授，中山大学肿瘤防治中心的曾木圣教授，美国 Wake Forest Baptist 的张微教授，美国 St. John's 大学的陈哲生教授等数十位全球知名专家。
编辑部基本信息
地址 北京市东城区东黄城根北街16号
电话 13910124623/010-64034856 邮箱 vcmeditor@ccm.cn
网站 https://vcm.edpsciences.org/
《可视化癌症医学（英文）》
（Visualized Cancer Medicine）投稿须知
【杂志社官方网站信息】
Visualized Cancer Medicine
Instructions for authors
1. General
1.1 Conditions of acceptance
Submission of a manuscript implies that the work has not been published and is not submitted for publication anywhere else. Publication must be approved by all authors. Authors should accept publication fees. For ethics in publishing consult COPE.
Authors are invited to comply with the “Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals”, which were established and made available by the International Committee of Medical Journal Editors (ICMJE) at: http://www.icmje.org/recommendations/.
1.2 Authorship
The ICMJE recommends that all those designated as authors meet all of the criteria they describe. The list of criteria is available at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/. Those contributors who do not meet all of the criteria shall be acknowledged.
1.3 Conflict of interest
Authors must disclose whether or not they have a financial relationship with the organization that sponsored the research. They should also state that they have full control of all primary data and that they agree to allow the journal to review their data if requested.
Therefore the manuscript must be accompanied by the "Conflicts of Interest Disclosure Form" at the initial submission.
Any additional conflict of interest, on personal or any other level must also be disclosed.
1.4 Publication Ethics and protection of research participants
All laws and regulations should be strictly followed. Authors are requested to indicate ethical declarations issued by their institution and concerning their research, including permit numbers, in the Material and Methods section. Authors are requested to fully comply with the ICMJE recommendations in this respect, particularly with the patient’s right to privacy, as well as the necessity to have the patient’s written consent.
1.5 Reporting guidelines and clinical trial registration
Depending on the study design, reporting guidelines such as CONSORT, STROBE, PRISMA, STARD should be followed. For more information about these guidelines authors should visit the websites of the EQUATOR network or the corresponding sources at the NLM website. The policy for clinical trial registration by the ICMJE is given in their recommendations. These should be followed by the authors in this journal.
1.6 Publication fees will be covered
Open Access journals have no income from institutional or membership subscriptions. The costs for the publication of these journals require the payment of article processing charges (APCs) or financial support.
For the journal Visualized Cancer Medicine, Zhongke Digital Publishing and Media Co., Ltd. (ZDP&M) will support the full publication costs of the articles. The authors have nothing to pay the first years before the journal gets indexed.
1.7 Open access
All articles published in Visualized Cancer Medicine are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Articles are available from the website of the journal (https://vcm.edpsciences.org/), from PubMed Central as soon as the indexation of the journal is effective and from Europe PubMed Central, in various formats. Authors are the copyright holders of their articles. All articles bear the following mention: This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.8 Manuscript compliance with the instructions for authors
Authors are invited to carefully read the below instructions. Articles not compliant with these instructions will be immediately sent back to the author. In order to avoid these additional delays in the publication of their articles, authors should know that their articles will enter the peer review process only if they are compliant after re-submission.
A frequent reason of immediate rejection is plagiarism. Using the Similarity Check tool for the text, allows to detect even minimal plagiarism. Thus authors are invited to read the ethical standards and apply the given indications in order to avoid this sanction.
1.9 Data sharing policy
Authors may be invited to share with the peer reviewers during the article evaluation process in a confidential manner the data on which the research is based. Further, as long as the publication of data is not in opposition with patients’ privacy, authors are invited to upload supplemental datasets related to their research to an online repository. Doing so makes it available for both human and machine reading in order to further aid the acceleration of scientific discovery.
Authors are invited to prepare and deposit their data according to the FAIR data principles. FAIR stands for Findable, Accessible, Interoperable and Re-usable. The principles are available here. To summarize this, the dataset should be findable through a complete set of metadata, including a license for re-use and a data identifier (DOI or other). The dataset is accessible when access is open. Interoperable means that the data can be used and combined with other datasets in a format that is sufficiently widely distributed. Re-usability is achieved when the dataset is deposited with a corresponding Creative Commons open license and is downloadable. Furthermore, re-usability implies that parameters describing how this dataset has been collected needs to be disclosed. Machine and experimental conditions must be documented.
1.10 Scientific Integrity
We hold scientific integrity as the top priority in any consideration of publication. Therefore, our authors are strongly suggested to upload their raw data onto Research Data Deposit (RDD) for further verification in case our readers have any doubt on the scientific integrity of the studied project. Please use this link for uploading your raw data onto RDD: http://www.researchdata.org.cn
2. Types of papers
Eleven types of publications are considered:
Original research article
Review article
Perspective article
Technological advances
Clinical case study
Laboratory bases methods
Surgical Techniques
Commentaries and historical reflections
Just movies
Editorial
Foreword
3. Presentation of manuscripts & videos
For manuscripts: Use Times 12 with 1.5 interline throughout the manuscript and avoid unnecessary formatting. Number pages. Use up to three subheading levels in total. Italics should be used in the text for all scientific names and other terms such as genes, mutations, genotypes and alleles. SI units should be used throughout the manuscript. Define acronyms/abbreviations upon first use in the main text. The manuscript must be submitted as an editable .doc or .docx or LaTeX file.
……
更多详情：
https://vcm.edpsciences.org/author-information/instructions-for-authors